LifeTech Scientific Corporation

DB:81X Stock Report

Market Cap: €773.4m

LifeTech Scientific Future Growth

Future criteria checks 5/6

LifeTech Scientific is forecast to grow earnings and revenue by 29.5% and 21.5% per annum respectively while EPS is expected to grow by 29.7% per annum.

Key information

29.5%

Earnings growth rate

29.7%

EPS growth rate

Medical Equipment earnings growth15.8%
Revenue growth rate21.5%
Future return on equityn/a
Analyst coverage

Low

Last updated31 Mar 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:81X - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,774399N/A4061
12/31/20241,474328N/A3251
6/30/20241,281249-58298N/A
3/31/20241,27425634358N/A
12/31/20231,267263125418N/A
9/30/20231,22429784393N/A
6/30/20231,18233143367N/A
3/31/20231,13932848378N/A
12/31/20221,09732553388N/A
9/30/20221,05831486437N/A
6/30/20221,019303119486N/A
3/31/2022972298108464N/A
12/31/202192529298441N/A
9/30/2021878307147436N/A
6/30/2021830322196432N/A
3/31/2021736269188385N/A
12/31/2020642216180339N/A
9/30/2020638176154303N/A
6/30/2020633136128268N/A
3/31/2020651132144271N/A
12/31/2019669129161275N/A
9/30/2019644138146252N/A
6/30/2019618146132229N/A
3/31/2019588134101206N/A
12/31/201855712170182N/A
9/30/201851813471190N/A
6/30/201848014772199N/A
3/31/2018445155N/A177N/A
12/31/2017409163N/A155N/A
9/30/2017391171N/A146N/A
6/30/2017373178N/A136N/A
3/31/2017363162N/A132N/A
12/31/2016353146N/A127N/A
9/30/2016336201N/A121N/A
6/30/2016319256N/A115N/A
3/31/2016315129N/A130N/A
12/31/20153122N/A144N/A
9/30/2015304-41N/A113N/A
6/30/2015296-84N/A81N/A
3/31/2015289-83N/A50N/A
12/31/2014283-81N/A20N/A
9/30/2014280-151N/AN/AN/A
6/30/2014258-209N/A6N/A
3/31/2014248-89N/AN/AN/A
12/31/2013231-66N/A35N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 81X's forecast earnings growth (29.5% per year) is above the savings rate (0.8%).

Earnings vs Market: 81X's earnings (29.5% per year) are forecast to grow faster than the German market (19.8% per year).

High Growth Earnings: 81X's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 81X's revenue (21.5% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: 81X's revenue (21.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 81X's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y